SUMMARY  

• The company cannot recommend any practices, procedures or usage that deviate from the approved labeling.
• Please refer to the local labeling and guidelines for relevant information regarding missed maintenance dose in adult patients receiving TREMFYA.

COMPANY CORE DATA SHEET

General Considerations for Administration

Subcutaneous administration

TREMFYA is intended for use under the guidance and supervision of a physician. TREMFYA may be administered by a health care professional, or a caregiver, or an adult patient may self-inject after proper training in subcutaneous injection technique.¹ 

If a dose is missed, administer the dose as soon as possible. Thereafter, resume dosing at the regular scheduled time.¹ 

Literature Search

A literature search of MEDLINE^®, EMBASE^®, BIOSIS Previews^®, and DERWENT^® (and/or other resources, including internal/external databases) was conducted on 03 April 2025.